UnitedHealth Q1 Revenue Rises 2% to $111.7B with EPS Beat, Raises 2026 Guidance
UnitedHealth reported Q1 revenue of $111.7 billion, up 2%, and EPS of $7.23, exceeding consensus. The company raised full-year 2026 EPS guidance to at least $18.25, forecasts double-digit growth through 2028 and trades at a 19.3 forward P/E below its decade average, implying fair value upside.
1. Q1 Financial Results
UnitedHealth reported Q1 revenue of $111.7 billion, up 2% year-over-year, while EPS reached $7.23, topping consensus estimates as aggressive repricing and AI-driven operational efficiencies bolstered margins.
2. Guidance Raise and Growth Outlook
The company raised its full-year 2026 EPS guidance to a minimum of $18.25, citing continued repricing actions and strategic portfolio exits, and forecasts double-digit annual growth through 2028.
3. Valuation and Market Implications
At a forward P/E of 19.3, below its ten-year average, UnitedHealth shares trade at a roughly 6% discount to a $369 fair value, suggesting potential double-digit annualized returns.